Enveric Biosciences Announces Withdrawal of Petition Against Its Patent

Stock Information for Enveric Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Enveric Biosciences Inc.

Enveric Biosciences Reports EB-003 BRET Receptor Engagement Assay Data
Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option
Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Enveric Biosciences Announces Patent Issuance
ENvue Medical Appoints Veteran Healthcare-Industry Executive, David Johnson, as Chairman
Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds
Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.